The goal of this clinical trial is to evaluate the effect of Ancestry, a supplement made from Mexican-origin foods (nopal, cacao, and cricket) in adults with Metabolic dysfunction-associated steatotic liver disease (MASLD). The main questions it aims to answer are:
* Does the supplementation with Ancestry improve the hepatic steatosis grade in participants with MASLD?
* Does the supplementation improve biochemical and anthropometric parameters in participants with MASLD?
* Does the supplementation enrich the abundance of beneficial bacteria in the gut microbiota of participants?
Researchers will compare the supplement group to a placebo group to see if the supplement is effective.
Participants will:
* Take the supplement or a placebo every day for 3 months.
* Receive nutritional guidance from a trained dietitian to control dietary intake.
* Attend follow-up clinic visits every month for monitoring and checkups.